Ratcliffe Liam
Insider CIK 1547100 · ARRY Director · CMRX 10% owner · MEIP 10% owner · CNCE 10% owner · IRTC 10% owner · RLYP · EDGE Director · VSAR 10% owner · DRTX 10% owner · OXFD · UMRX Director · OKUR Director · DCPH Director, 10% owner · ARVN Director · ITRM 10% owner · APTX Director, 10% owner · ELYM Director · PASG Director · IRON Director · UPB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2026-06-18 | 2026-06-23 | 6,212 | — | $0 | 6,212 | SEC↗ |
| UPB Upstream Bio, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 17,096 | — | $0 | 17,096 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 1,275 | — | $0 | 1,275 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-03-31 | 2026-04-01 | 15,300 | — | $0 | 15,300 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| UPB Upstream Bio, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 17,096 | — | $0 | 17,096 | SEC↗ |
| UPB Upstream Bio, Inc. | A Award deriv | 2024-10-10 | 2024-10-15 | 17,096 | — | $0 | 17,096 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2023-06-09 | 2023-06-09 | 7,136 | — | $0 | 7,136 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2023-05-18 | 2023-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2022-12-29 | 2023-01-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2022-05-19 | 2022-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-12-16 | 2021-12-16 | 37,206 | $68.97 | $2.57M | 185,686 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-12-16 | 2021-12-16 | 48,499 | $69.66 | $3.38M | 222,892 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-12-15 | 2021-12-16 | 67,549 | $66.50 | $4.49M | 277,086 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-12-15 | 2021-12-16 | 40,292 | $67.46 | $2.72M | 344,635 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-12-15 | 2021-12-16 | 5,695 | $65.74 | $374.4K | 271,391 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-12-14 | 2021-12-16 | 700 | $64.20 | $44.9K | 384,927 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-12-14 | 2021-12-16 | 36,308 | $65.38 | $2.37M | 385,627 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-12-14 | 2021-12-16 | 119,456 | $66.01 | $7.89M | 421,935 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-15 | 2021-11-15 | 3,532 | $83.90 | $296.3K | 541,391 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-15 | 2021-11-15 | 17,752 | $85.07 | $1.51M | 544,923 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-12 | 2021-11-15 | 12,760 | $84.02 | $1.07M | 562,675 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-12 | 2021-11-15 | 9,660 | $84.31 | $814.4K | 575,435 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-12 | 2021-11-15 | 17,449 | $85.96 | $1.50M | 585,095 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-11 | 2021-11-15 | 18,007 | $86.38 | $1.56M | 638,754 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-11 | 2021-11-15 | 5,582 | $87.71 | $489.6K | 656,761 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-11 | 2021-11-15 | 36,210 | $85.92 | $3.11M | 602,544 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-10 | 2021-11-15 | 1,498 | $89.16 | $133.6K | 672,351 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-10 | 2021-11-15 | 199 | $86.59 | $17.2K | 662,343 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-10 | 2021-11-15 | 3,956 | $87.11 | $344.6K | 662,542 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-10 | 2021-11-15 | 5,853 | $88.12 | $515.8K | 666,498 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-10 | 2021-11-15 | 1,852 | $90.18 | $167.0K | 673,849 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-09 | 2021-11-09 | 5,131 | $92.73 | $475.8K | 703,578 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-09 | 2021-11-09 | 580 | $91.33 | $53.0K | 675,701 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-09 | 2021-11-09 | 27,297 | $91.85 | $2.51M | 676,281 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-08 | 2021-11-09 | 54,568 | $94.93 | $5.18M | 735,195 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-08 | 2021-11-09 | 11,668 | $94.20 | $1.10M | 723,527 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-08 | 2021-11-09 | 11,130 | $93.03 | $1.04M | 712,397 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-08 | 2021-11-09 | 3,688 | $92.48 | $341.1K | 708,709 | SEC↗ |
| ARVN ARVINAS, INC. | M Exercise deriv | 2021-11-05 | 2021-11-09 | 6,423 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS, INC. | M Exercise deriv | 2021-11-05 | 2021-11-09 | 12,000 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS, INC. | M Exercise | 2021-11-05 | 2021-11-09 | 12,000 | $33.57 | $402.8K | 24,923 | SEC↗ |
| ARVN ARVINAS, INC. | M Exercise | 2021-11-05 | 2021-11-09 | 6,423 | $22.06 | $141.7K | 12,923 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-05 | 2021-11-09 | 6,423 | $91.50 | $587.7K | 18,500 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-05 | 2021-11-09 | 7,060 | $91.50 | $646.0K | 11,440 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-05 | 2021-11-09 | 4,940 | $90.75 | $448.3K | 6,500 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-05 | 2021-11-09 | 5,221 | $91.59 | $478.2K | 1,279 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-05 | 2021-11-09 | 795 | $90.29 | $71.8K | 484 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-05 | 2021-11-09 | 484 | $89.65 | $43.4K | 0 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-05 | 2021-11-09 | 4,519 | $94.08 | $425.1K | 818,338 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-05 | 2021-11-09 | 1,825 | $93.03 | $169.8K | 816,513 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-05 | 2021-11-09 | 15,327 | $91.81 | $1.41M | 801,186 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-05 | 2021-11-09 | 8,676 | $91.09 | $790.3K | 792,510 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-11-05 | 2021-11-09 | 2,747 | $89.86 | $246.8K | 789,763 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2021-08-09 | 2021-08-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2021-06-08 | 2021-06-10 | 7,511 | — | $0 | 7,511 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2021-05-27 | 2021-05-28 | 16,918 | — | $0 | 16,918 | SEC↗ |
| ARVN ARVINAS, INC. | P Buy | 2020-12-18 | 2020-12-21 | 142,857 | $70.00 | $10.00M | 822,857 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2020-06-03 | 2020-06-04 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ARVN ARVINAS, INC. | M Exercise deriv | 2020-05-26 | 2020-05-27 | 6,500 | — | $0 | 6,423 | SEC↗ |
| ARVN ARVINAS, INC. | M Exercise | 2020-05-26 | 2020-05-27 | 6,500 | $22.06 | $143.4K | 6,500 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion deriv | 2020-03-03 | 2020-03-13 | 2,066,630 | — | $0 | 0 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2020-03-03 | 2020-03-03 | 2,800 | $18.00 | $50.4K | 2,800 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2020-03-03 | 2020-03-13 | 2,800 | $18.00 | $50.4K | 2,800 | SEC↗ |
| PASG Passage BIO, Inc. | C Conversion | 2020-03-03 | 2020-03-13 | 2,066,630 | — | $0 | 2,066,630 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2020-03-03 | 2020-03-13 | 550,000 | $18.00 | $9.90M | 2,616,630 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2020-02-27 | 2020-03-02 | 33,836 | — | $0 | 33,836 | SEC↗ |
| ARVN ARVINAS, INC. | P Buy | 2019-11-12 | 2019-11-14 | 680,000 | $22.00 | $14.96M | 680,000 | SEC↗ |
| UMRX Unum Therapeutics Inc. | A Award deriv | 2019-06-14 | 2019-06-18 | 7,881 | $1.67 | $13.2K | 7,881 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2019-05-23 | 2019-05-28 | 12,923 | — | $0 | 12,923 | SEC↗ |
| UMRX Unum Therapeutics Inc. | A Award deriv | 2019-04-01 | 2019-04-03 | 4,829 | $2.72 | $13.1K | 4,829 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2019-03-29 | 2019-04-02 | 4,123 | $2.43 | $10.0K | 4,123 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise deriv | 2019-03-15 | 2019-03-18 | 10,000 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise | 2019-03-15 | 2019-03-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| UMRX Unum Therapeutics Inc. | A Award deriv | 2019-01-02 | 2019-01-04 | 4,860 | $2.70 | $13.1K | 4,860 | SEC↗ |
| UMRX Unum Therapeutics Inc. | A Award deriv | 2018-10-01 | 2018-10-03 | 2,111 | $6.22 | $13.1K | 2,111 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion deriv | 2018-10-01 | 2018-10-03 | 3,601,657 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion deriv | 2018-10-01 | 2018-10-03 | 568,252 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS INC. | P Buy | 2018-10-01 | 2018-10-03 | 375,000 | $16.00 | $6.00M | 375,000 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion | 2018-10-01 | 2018-10-03 | 1,108,202 | — | $0 | 1,108,202 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion | 2018-10-01 | 2018-10-03 | 174,846 | — | $0 | 1,283,048 | SEC↗ |
| ARVN ARVINAS INC. | P Buy | 2018-10-01 | 2018-10-03 | 625,000 | $16.00 | $10.00M | 1,908,048 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-08-14 | 2018-08-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| UMRX Unum Therapeutics Inc. | A Award deriv | 2018-07-26 | 2018-09-26 | 1,504 | $8.72 | $13.1K | 1,504 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 33,022,786 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 15,233,315 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 6,712,986 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 28,895,188 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 1,197,076 | — | $0 | 2,244,526 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 1,047,450 | — | $0 | 1,047,450 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 125,000 | $16.00 | $2.00M | 368,345 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 125,000 | $16.00 | $2.00M | 2,921,734 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 243,345 | — | $0 | 243,345 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 552,208 | — | $0 | 2,796,734 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-31 | 148,603 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-31 | 466,793 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-31 | 178,230 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-31 | 148,603 | — | $0 | 793,626 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-31 | 466,793 | — | $0 | 466,793 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-31 | 278,062 | $13.00 | $3.61M | 1,071,688 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-31 | 178,230 | — | $0 | 645,023 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-31 | 384,615 | $13.00 | $5.00M | 384,615 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2018-05-17 | 2018-05-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion deriv | 2018-04-03 | 2018-04-03 | 977,835 | — | $0 | 0 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion deriv | 2018-04-03 | 2018-04-03 | 977,836 | — | $0 | 0 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion | 2018-04-03 | 2018-04-03 | 622,772 | — | $0 | 622,772 | SEC↗ |
| UMRX Unum Therapeutics Inc. | C Conversion | 2018-04-03 | 2018-04-03 | 622,773 | — | $0 | 622,773 | SEC↗ |
| UMRX Unum Therapeutics Inc. | P Buy | 2018-04-03 | 2018-04-03 | 275,000 | $12.00 | $3.30M | 897,772 | SEC↗ |
| UMRX Unum Therapeutics Inc. | P Buy | 2018-04-03 | 2018-04-03 | 275,000 | $12.00 | $3.30M | 897,773 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion deriv | 2017-10-02 | 2017-10-02 | 148,515 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion deriv | 2017-10-02 | 2017-10-02 | 198,004 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion deriv | 2017-10-02 | 2017-10-02 | 49,505 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion deriv | 2017-10-02 | 2017-10-02 | 65,997 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion deriv | 2017-10-02 | 2017-10-02 | 198,004 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion | 2017-10-02 | 2017-10-02 | 1,118,722 | — | $0 | 1,957,832 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | P Buy | 2017-10-02 | 2017-10-02 | 375,000 | $17.00 | $6.38M | 2,146,308 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion | 2017-10-02 | 2017-10-02 | 279,703 | — | $0 | 279,703 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion | 2017-10-02 | 2017-10-02 | 1,118,722 | — | $0 | 1,398,425 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion | 2017-10-02 | 2017-10-02 | 372,883 | — | $0 | 1,771,308 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion | 2017-10-02 | 2017-10-02 | 839,110 | — | $0 | 839,110 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2017-06-20 | 2017-06-21 | 15,000 | $10.15 | $152.3K | 15,000 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 190,154 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 610,136 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 155,548 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 72,389 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | P Buy | 2016-10-25 | 2016-10-25 | 25,000 | $17.00 | $425.0K | 1,741,589 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion | 2016-10-25 | 2016-10-25 | 1,716,589 | — | $0 | 1,716,589 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2016-06-21 | 2016-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2015-03-24 | 2015-03-26 | 1,601,390 | $1.97 | $3.15M | 0 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2014-12-18 | 2014-12-22 | 150,000 | $19.01 | $2.85M | 2,409,374 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2014-12-09 | 2014-12-10 | 70,081 | $6.01 | $421.2K | 1,601,390 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2014-12-08 | 2014-12-10 | 9,004 | $6.05 | $54.5K | 1,671,471 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 3,028,439 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2014-11-11 | 2014-11-13 | 800,000 | $19.37 | $15.50M | 2,559,374 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2014-09-29 | 2014-10-01 | 12,556 | $20.02 | $251.4K | 3,359,374 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 8,439,620 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 1,349,433 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 20,942,466 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 3,546,094 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 3,050,019 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | X Exercise deriv | 2014-03-27 | 2014-03-28 | 759,565 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 759,565 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2014-03-27 | 2014-03-28 | 60,000 | $21.02 | $1.26M | 3,371,930 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 1,821,084 | — | $0 | 1,821,084 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 66,049 | — | $0 | 3,311,930 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 308,356 | — | $0 | 3,245,881 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 117,342 | — | $0 | 2,937,525 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 265,219 | — | $0 | 2,820,183 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 733,880 | — | $0 | 2,554,964 | SEC↗ |
| CMRX CHIMERIX INC | J Other | 2014-03-18 | 2014-03-20 | 700,000 | — | $0 | 1,543,394 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 442,478 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 77,522 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 13,721 | — | $0 | 107,327 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 78,315 | — | $0 | 93,606 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-11-21 | 2013-11-25 | 365,000 | $8.25 | $3.01M | 1,680,475 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 259,676 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 497,093 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 25,977 | — | $0 | 25,977 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 25,977 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 378,773 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 541,960 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 125,067 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 17,671 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 497,093 | — | $0 | 497,093 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 125,067 | — | $0 | 1,924,626 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 378,773 | — | $0 | 1,257,599 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 541,960 | — | $0 | 1,799,559 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 381,733 | — | $0 | 878,826 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 25,977 | $9.18 | $238.5K | 1,950,603 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 21,691 | $11.00 | $238.6K | 1,928,912 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2013-11-20 | 2013-11-20 | 185,978 | $11.00 | $2.05M | 2,114,890 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2013-10-23 | 2013-10-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-09-27 | 2013-09-30 | 863,521 | $5.99 | $5.17M | 0 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-09-26 | 2013-09-30 | 262,207 | $6.02 | $1.58M | 863,521 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-09-16 | 2013-09-16 | 319,033 | $6.14 | $1.96M | 1,125,728 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-09-13 | 2013-09-16 | 546,660 | $6.01 | $3.29M | 1,444,761 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-09-12 | 2013-09-16 | 807,479 | $6.10 | $4.93M | 1,991,421 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-09-06 | 2013-09-06 | 139,572 | $5.68 | $792.8K | 2,798,900 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-09-05 | 2013-09-06 | 201,598 | $5.77 | $1.16M | 2,938,472 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | S Sale | 2013-09-04 | 2013-09-06 | 236,116 | $5.87 | $1.39M | 3,140,070 | SEC↗ |
| ARRY ARRAY BIOPHARMA INC | A Award deriv | 2012-10-24 | 2012-10-26 | 20,000 | — | $0 | 20,000 | SEC↗ |